• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘤周水肿可作为高级别胶质瘤复发模式和无复发生存的独立预测因素。

Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.

机构信息

School of Medical Imaging, Xuzhou Medical University, Xuzhou 221000, China.

Department of Radiation Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China.

出版信息

Comput Math Methods Med. 2022 Jul 27;2022:9547166. doi: 10.1155/2022/9547166. eCollection 2022.

DOI:10.1155/2022/9547166
PMID:35936378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9348930/
Abstract

OBJECTIVE

This study is aimed at analyzing the factors affecting the recurrence patterns and recurrence-free survival (RFS) of high-grade gliomas (HGG).

METHODS

Eligible patients admitted to the Affiliated Hospital of Xuzhou Medical University were selected. Subsequently, the effects of some clinical data including age, gender, WHO pathological grades, tumor site, tumor size, clinical treatments, and peritumoral edema (PTE) area and molecular markers (Ki-67, MGMT, IDH-1, and p53) on HGG patients' recurrence patterns and RFS were analyzed.

RESULTS

A total number of 77 patients were enrolled into this study. After analyzing all the cases, it was determined that tumor size and tumor site had a significant influence on the recurrent patterns of HGG, and PTE was an independent predict factor of recurrence patterns. Specifically, when the PTE was mild (<1 cm), the recurrence pattern tended to be local; in contrast, HGG was more likely to progress to marginal recurrence and distant recurrence. Furthermore, age and PTE were significantly associated with RFS; the median RFS of the population with PTE < 1 cm (23.60 months) was obviously longer than the population with PTE ≥ 1 cm (5.00 months).

CONCLUSIONS

PTE is an independent predictor of recurrence patterns and RFS for HGG. Therefore, preoperative identification of PTE in HGG patients is crucially important, which is helpful to accurately estimate the recurrence pattern and RFS.

摘要

目的

本研究旨在分析影响高级别胶质瘤(HGG)复发模式和无复发生存(RFS)的因素。

方法

选取徐州医科大学附属医院收治的符合条件的患者。随后,分析了一些临床数据对 HGG 患者复发模式和 RFS 的影响,包括年龄、性别、世界卫生组织(WHO)病理分级、肿瘤部位、肿瘤大小、临床治疗以及瘤周水肿(PTE)面积和分子标志物(Ki-67、MGMT、IDH-1 和 p53)。

结果

本研究共纳入 77 例患者。对所有病例进行分析后发现,肿瘤大小和肿瘤部位对 HGG 的复发模式有显著影响,PTE 是复发模式的独立预测因素。具体来说,当 PTE 轻度(<1cm)时,肿瘤复发模式倾向于局部;相反,HGG 更有可能进展为边缘性复发和远处复发。此外,年龄和 PTE 与 RFS 显著相关;PTE<1cm 人群的中位 RFS(23.60 个月)明显长于 PTE≥1cm 人群(5.00 个月)。

结论

PTE 是 HGG 复发模式和 RFS 的独立预测因素。因此,术前识别 HGG 患者的 PTE 至关重要,有助于准确评估复发模式和 RFS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/2ba4a01be890/CMMM2022-9547166.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/569010fe1568/CMMM2022-9547166.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/7001b54bd1e9/CMMM2022-9547166.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/b998f9e19903/CMMM2022-9547166.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/973f1b958294/CMMM2022-9547166.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/cc816e3ea72f/CMMM2022-9547166.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/2ba4a01be890/CMMM2022-9547166.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/569010fe1568/CMMM2022-9547166.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/7001b54bd1e9/CMMM2022-9547166.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/b998f9e19903/CMMM2022-9547166.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/973f1b958294/CMMM2022-9547166.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/cc816e3ea72f/CMMM2022-9547166.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8163/9348930/2ba4a01be890/CMMM2022-9547166.006.jpg

相似文献

1
Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.瘤周水肿可作为高级别胶质瘤复发模式和无复发生存的独立预测因素。
Comput Math Methods Med. 2022 Jul 27;2022:9547166. doi: 10.1155/2022/9547166. eCollection 2022.
2
Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.小热休克蛋白 B11 与高级别脑胶质瘤患者 MGMT 启动子甲基化的预后价值之间的关系。
J Neurosurg. 2016 Jul;125(1):7-16. doi: 10.3171/2015.5.JNS142437. Epub 2015 Nov 6.
3
AQP-4 in peritumoral edematous tissue is correlated with the degree of glioma and with expression of VEGF and HIF-alpha.瘤周水肿组织中的 AQP-4 与胶质瘤的程度以及 VEGF 和 HIF-α的表达相关。
J Neurooncol. 2010 Dec;100(3):375-83. doi: 10.1007/s11060-010-0205-x. Epub 2010 May 14.
4
Patterns of Failure After Stereotactic Radiosurgery for Recurrent High-Grade Glioma: A Single Institution Experience of 10 Years.立体定向放射外科治疗复发性高级别胶质瘤后的失败模式:单机构 10 年经验。
Neurosurgery. 2019 Aug 1;85(2):E322-E331. doi: 10.1093/neuros/nyy520.
5
Patterns of local failure in patients with high-grade glioma after postoperative radiotherapy with or without chemotherapy.接受或未接受化疗的高级别胶质瘤患者术后放疗后的局部失败模式。
Transl Cancer Res. 2019 Jun;8(3):985-991. doi: 10.21037/tcr.2019.05.33.
6
Comparison of F-GE-180 and dynamic F-FET PET in high grade glioma: a double-tracer pilot study.F-GE-180 与动态 F-FET PET 对比在高级别胶质瘤中的应用:一项双示踪剂初步研究。
Eur J Nucl Med Mol Imaging. 2019 Mar;46(3):580-590. doi: 10.1007/s00259-018-4166-1. Epub 2018 Sep 22.
7
Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?贝伐单抗联合再放疗治疗复发性高级别胶质瘤:顺序重要吗?
J Neurooncol. 2018 Dec;140(3):623-628. doi: 10.1007/s11060-018-2989-z. Epub 2018 Sep 4.
8
Correlation of high delta-like ligand 4 expression with peritumoral brain edema and its prediction of poor prognosis in patients with primary high-grade gliomas.高Delta样配体4表达与原发性高级别胶质瘤患者瘤周脑水肿的相关性及其对预后不良的预测
J Neurosurg. 2015 Dec;123(6):1578-85. doi: 10.3171/2014.12.JNS14768. Epub 2015 Jun 5.
9
A Nomogram for Predicting Early Recurrence in Patients with High-Grade Gliomas.用于预测高级别胶质瘤患者早期复发的列线图
World Neurosurg. 2022 Aug;164:e619-e628. doi: 10.1016/j.wneu.2022.05.039. Epub 2022 May 16.
10
Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.复发恶性脑胶质瘤的肿瘤形态学和瘤周水肿与经鼻给予紫苏醇治疗反应的相关性。
Invest New Drugs. 2009 Dec;27(6):557-64. doi: 10.1007/s10637-008-9215-3. Epub 2009 Jan 13.

引用本文的文献

1
Peritumoral Edema in Gliomas: A Review of Mechanisms and Management.胶质瘤中的瘤周水肿:机制与治疗综述
Biomedicines. 2023 Oct 9;11(10):2731. doi: 10.3390/biomedicines11102731.
2
Retracted: Peritumor Edema Serves as an Independent Predictive Factor of Recurrence Patterns and Recurrence-Free Survival for High-Grade Glioma.撤回:瘤周水肿是高级别胶质瘤复发模式和无复发生存的独立预测因素。
Comput Math Methods Med. 2023 Jul 19;2023:9761763. doi: 10.1155/2023/9761763. eCollection 2023.

本文引用的文献

1
Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.中国新诊断多形性胶质母细胞瘤患者对 Stupp 方案的依从性。
Future Oncol. 2021 Nov;17(33):4571-4582. doi: 10.2217/fon-2021-0435. Epub 2021 Sep 14.
2
Phosphatidylinositol 3,4,5-Trisphosphate-Dependent Rac Exchanger 2 Protein Facilitates Glioma Progression via Akt and Stat3 Signaling.磷脂酰肌醇3,4,5-三磷酸依赖性Rac交换蛋白2通过Akt和Stat3信号促进胶质瘤进展。
J Mol Neurosci. 2021 Aug;71(8):1674-1682. doi: 10.1007/s12031-021-01883-x. Epub 2021 Jul 28.
3
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
4
Prognostic relevance of CSF and peri-tumoral edema volumes in glioblastoma.胶质母细胞瘤中脑脊液和瘤周水肿体积的预后相关性
J Clin Neurosci. 2021 Feb;84:1-7. doi: 10.1016/j.jocn.2020.12.014. Epub 2020 Dec 28.
5
Multifunctionalized Gold Sub-Nanometer Particles for Sensitizing Radiotherapy against Glioblastoma.多功能化金亚纳米粒子增敏放疗治疗脑胶质母细胞瘤
Small. 2021 Feb;17(5):e2006582. doi: 10.1002/smll.202006582. Epub 2020 Dec 31.
6
Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives.复发性胶质母细胞瘤:从分子格局到新的治疗前景
Cancers (Basel). 2020 Dec 26;13(1):47. doi: 10.3390/cancers13010047.
7
Role of Exosomes in the Progression, Diagnosis, and Treatment of Gliomas.外泌体在胶质瘤进展、诊断及治疗中的作用
Med Sci Monit. 2020 Nov 27;26:e924023. doi: 10.12659/MSM.924023.
8
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.成人脑胶质母细胞瘤:神经肿瘤学会(SNO)和欧洲神经肿瘤学会(EANO)关于当前管理和未来方向的共识综述。
Neuro Oncol. 2020 Aug 17;22(8):1073-1113. doi: 10.1093/neuonc/noaa106.
9
Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy.高级别胶质瘤的生物肿瘤内治疗 第二部分:基于载体和细胞的治疗以及放射免疫治疗
CNS Oncol. 2019 Nov 1;8(3):CNS40. doi: 10.2217/cns-2019-0002. Epub 2019 Nov 21.
10
Controversial roles for dexamethasone in glioblastoma - Opportunities for novel vascular targeting therapies.地塞米松在胶质母细胞瘤中的争议性作用——新型血管靶向治疗的机会。
J Cereb Blood Flow Metab. 2019 Aug;39(8):1460-1468. doi: 10.1177/0271678X19859847. Epub 2019 Jun 25.